Brief: Algorae Pharmaceuticals Signs Exclusive License Agreement With Sakar
22/09/2025 23:56
Sept 23 (Reuters) - Algorae Pharmaceuticals Ltd 1AI.AX: ALGORAE SIGNS EXCLUSIVE LICENSE AGREEMENT WITH SAKAR DEAL FOR LAUNCHING 5 GENERIC ONCOLOGY MEDICINES INTO AUSTRALIAN, NZ MARKETS Further company coverage: 1AI.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Algorae Pharmaceuticals
See all newsBrief: Algorae Pharmaceuticals Executes License & Supply Agreement With Torrent Pharma
Brief: Algorae Pharmaceuticals And Zydus Enter Exclusive Commercial Agreement
Brief: Algorae Pharmaceuticals Raises A$3.9 Million At A$0.012 Per Share
Brief: Algorae Pharmaceuticals Says TGA Accepts Initial Registration Dossier For Evaluation
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre For Second AI-Driven Drug Synergy Screening Program